Please join us for a kick-off meeting of the Laboratory Access and Benefits (LAB) Coalition on July 8, 2021 at 2:00 p.m. EST. Representatives from the Food and Drug Administration will join the meeting and provide brief remarks. We look forward to discussing opportunities in lab policy and hearing from participants on these important issues.
Agenda:
Welcome and Introductions
Brief Remarks from FDA
Elizabeth Hillebrenner, Associate Director for Scientific and Regulatory Programs, Center for Devices and Radiological Health
Brief Remarks from Avalon Healthcare Solutions CEO, Dr. Bill Kerr
Review and Discussion of Four Proposed Policy Focus Areas
Cost and Reimbursement
Medical Necessity and Prior Authorization
Oversight and Regulatory Authority
Access, Equity, and Value-based Arrangements
Joining LAB: Membership Overview
Wrap-up & Next Steps
Missed the meeting and want to learn more? Please contact bmeeks@labcoalition.org or smcgurl@labcoalition.org